This company has been acquired
Science 37 Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Science 37 Holdings has a total shareholder equity of $51.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $75.7M and $24.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$56.41m |
| Equity | US$51.74m |
| Total liabilities | US$23.98m |
| Total assets | US$75.73m |
Recent financial health updates
Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans
Apr 11
We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth
Nov 04Recent updates
Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks
Dec 18Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)
Apr 17Science 37, Syapse team for faster patient enrollment in cancer trials
Aug 18Science 37 reports Q2 mixed earnings; narrows FY22 guidance
Aug 11Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
May 13Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans
Apr 11Science 37: Pioneering Decentralized Clinical Trials
Jan 02We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth
Nov 04Financial Position Analysis
Short Term Liabilities: SNCE's short term assets ($75.5M) exceed its short term liabilities ($18.1M).
Long Term Liabilities: SNCE's short term assets ($75.5M) exceed its long term liabilities ($5.9M).
Debt to Equity History and Analysis
Debt Level: SNCE is debt free.
Reducing Debt: SNCE has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SNCE has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SNCE has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 36.9% each year.